Gene content    
NF2 ( by HUGO)
Neurofibromin
Tumor suppressor gene
Neurofibromin 2 (Merlin)
Neurofibromin 2 (Bilateral Acoustic Neuroma)
Moesin-Ezrin-Radixin Like
schwannomin
Moesin-Ezrin-Radixin-Like Protein
SCH
ACN
BANF
merlin
Moesin-Ezrin-Radizin-Like Protein
neurofibromin-2
schwannomerlin
Neurofibromin-2
Schwannomerlin
Schwannomin
NCBI: 22q12.2    Ensembl: 22q12.2
MERL_HUMANSize: 595 amino acidsMass: 69690 Da

  • Subunit: Interacts with SLC9A3R1, HGS and AGAP2. Interacts with LAYN (By similarity). Interacts with SGSM3. Interacts (via FERM domain) with MPP1. Interacts with WWC1. Interacts with the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex. The unphosphorylated form interacts (via FERM domain) with VPRBP/DCAF1 2 PDB 3D structures from [IMAGE] and Proteopedia [IMAGE] for NF2: 1H4R (3D) [IMAGE] 3U8Z (3D) [IMAGE]
  • Tissue specificity: Widely expressed. Isoform 1 and isoform 3 are predominant. Isoform 4, isoform 5 and isoform 6 are expressed moderately. Isoform 8 is found at low frequency. Isoform 7, isoform 9 and isoform 10 are not expressed in adult tissues, with the exception of adul
  • Function:
    UniProtKB/Swiss-Prot Summary: MERL_HUMAN, P35240 Function: Probable regulator of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway, a signaling pathway that plays a pivotal role in tumor suppression by restricting proliferation and promoting apoptosis. Along with WWC1 can synergistically induce the phosphorylation of LATS1 and LATS2 and can probably function in the regulation of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway. May act as a membrane stabilizing protein. May inhibit PI3 kinase by binding to AGAP2 and impairing its stimulating activity. Suppresses cell proliferation and tumorigenesis by inhibiting the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex
  • Similarity:
    Contains 1 FERM domain [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR000299FERM_domainBand 4.1Domain
    IPR000798Ez/rad/moesin_likeEzrin/radixin/moesin ERMFamily
    IPR008954Moesin_tailMoesinDomain
    IPR011174ERMEzrin/radixin/moesinFamily
    IPR011259ERM_C_domEzrin/radixin/moesin, C-terminalDomain
    IPR011993PH_like_domPleckstrin homology-typeDomain
    BlocksIPB000299Band 4.1 domainBand 4.1 domain
    IPB000798ERM family signatureERM family signature

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process actin cytoskeleton organization IMP GOA 9537418
    negative regulation of cell migration TAS GOA 17210637
    negative regulation of cell proliferation IMP GOA 17210637
    negative regulation of cell proliferation IDA GOA 12444102
    negative regulation of cell-cell adhesion IDA GOA 17210637
    negative regulation of cell-matrix adhesion TAS GOA 17210637
    negative regulation of DNA replication IMP GOA 17210637
    negative regulation of JAK-STAT cascade IDA GOA 12444102
    negative regulation of tyrosine phosphorylation of Stat3 protein IDA GOA 12444102
    negative regulation of tyrosine phosphorylation of Stat5 protein IDA GOA 12444102
    positive regulation of stress fiber assembly IMP GOA 9537418
    Schwann cell proliferation IMP GOA 17353411
    Cellular Component cytoskeleton TAS GOA 8379998
    early endosome IDA GOA 10861283
    membrane IDA GOA 19946888
    nucleolus IDA GOA 9537418
    nucleus IDA GOA 10401006
    perinuclear region of cytoplasm IDA GOA 17210637
    Molecular Function protein binding IPI GOA 10669747

    Disorder & Mutation    
    Source Disease
    Genatlasneurofibromatosis 2,autosomal dominant disorder characterized by tumors of neural-crest origin cells,with biallelic inactivation in schwannomas,meningiomas,mesotheliomas,and testicular anomalies such as presenile lens opacities and retinal hamartomas,(merlin/Schwannomin defect)
    SWISS-PROTSchwannomatosis (SCHWA) [MIM:162091]: Schwannomas are benign tumors of the peripheral nerve sheath that usually occur singly in otherwise normal individuals. Multiple schwannomas in the same individual suggest an underlying tumor-predisposition syndrome. The most common such syndrome is NF2. The hallmark of NF2 is the development of bilateral vestibular-nerve schwannomas; but two-thirds or more of all NF2-affected individuals develop schwannomas in other locations, and dermal schwannomas may precede vestibular tumors in NF2-affected children. There have been several reports of individuals with multiple schwannomas who do not show evidence of vestibular schwannoma. Clinical report suggests that schwannomatosis is a clinical entity distinct from other forms of neurofibromatosis. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTNeurofibromatosis 2 (NF2) [MIM:101000]: Genetic disorder characterized by bilateral vestibular schwannomas (formerly called acoustic neuromas), schwannomas of other cranial and peripheral nerves, meningiomas, and ependymomas. It is inherited in an autosomal dominant fashion with full penetrance. Affected individuals generally develop symptoms of eighth-nerve dysfunction in early adulthood, including deafness and balance disorder. Although the tumors of NF2 are histologically benign, their anatomic location makes management difficult, and patients suffer great morbidity and mortality. Note=The disease is caused by mutations affecting the gene represented in this entry

    NF2 cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene